Jony Musky

@vercel Don't forget the VERCEL_AUTOMATION_BYPASS_SECRET :)

@martinvars @certumaai Hi Martin, just sent you a DM

@MS_BASE44 Love this initiatives

I'm looking to invest in cancer research and breakthrough treatment companies Cancer is humanity's worst enemy, and unfortunately, it's one of the few frontier problems i don't see getting solved in the next 2-3 years.  I'll be able to write checks up to a few million (usually up to a million).  I will work extremely hard to help the founders. I'll leverage my network as much as possible to overcome bureaucracies and help hunt down talent for every company I'm investing in. Things I'm particularly interested in:  1. Accelerating clinical trials: As AI gets smarter and allows novel hypotheses on new drug targets, clinical trials and bureaucracy will remain the biggest bottleneck to fight cacner. 2. Repurposed drugs: the current cost of Phase 3 clinical trials only allows patentable solutions to be economically viable. It resonates that are probably many other treatments and potentially impactful drugs that won't be included in the Standard of Care as they haven't gone through phase 3 clinical trials.  3. Personalized medicine: organoids, digital twin, faster cycle from biopsy -> identifying targets -> creating customised solutions, such as mRNA vaccines, custom Antibody-Drug Conjugates (ADCs), and novel ways of triggering one's immune system.  4. Improving measurement: Currently, the standard PET-CT method does not allow weekly measurement of disease progression. Identifying a superior method to allow weekly measurement of progression could be instrumental in cutting down the time it takes to find a drug the body respond to. Anyone who can connect me to relevant companies will be widely appreciated

@willahmed @franco_goytia Congrats 👏🏻👏🏻👏🏻

T-3min 🌚🚀🚀🚀🚀

Buena jugada la de Vercel y ponerte a clippy

@Contexto_Visual Buen entrenamiento para pilotear un F1